Profiling cellular metabolism in the FBR could identify novel therapeutic targets and promote biocompatibility.
No takes yet. Share an insight, caveat, or question.
Callaghan et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: